Dr. Anthony Mastroianni, MD

Dr. Mastroianni practices at Fairview Hospital in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Mastroianni's NPI, 1265517403, was assigned on October 26, 2006. Dr. Mastroianni graduated from Cleveland Medical College, Homeopathic in 1992. Dr. Mastroianni holds Ohio license 35065807M.

Dr. Mastroianni's primary practice is Fairview Hospital, at 18101 Lorain Avenue, Cleveland, OH 44111 in Cuyahoga County. The practice phone is (216) 476-7000.

Dr. Mastroianni's primary practice is Fairview Hospital in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Mastroianni is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Mastroianni to 1 more hospital, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mastroianni practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Mastroianni's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mastroianni is board certified in radiation oncology by the American Board of Radiology. Dr. Mastroianni is licensed in Ohio.

Dmand AI lists anal cancer radiation, bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Mastroianni treats.

CMS data shows 2,616 Medicare services from Dr. Mastroianni across 22 procedure codes in 2024, for 281 Medicare patients. Medicare paid $197,092 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 281 Medicare patients who saw Dr. Mastroianni in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mastroianni's median patient age at 70, with 56% women.

In 2024, Dr. Mastroianni wrote 112 Medicare Part D claims for 56 patients. 99% of them were for generic drugs. CMS names the drug for 71 of them, across 3 drugs with 11 or more claims each, at $758 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

Dr. Mastroianni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mastroianni as offering telehealth.

Dmand AI links 5 papers to Dr. Mastroianni, published from 2016 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Radiotherapy Planning, Computer-Assisted, Radiosurgery and Radiotherapy, Intensity-Modulated. Dr. Mastroianni has published most often in J Appl Clin Med Phys. Dr. Mastroianni's most frequent co-authors are John H. Suh, MD, Samuel T. Chao, MD and John F. Greskovich, MD.

CMS Open Payments shows 1 general payment to Dr. Mastroianni from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Teleflex LLC paid the most, $30.

Dmand AI lists 1 award for Dr. Mastroianni, most recently CMS Stage 1 EHR in 2013.

Dr. Mastroianni graduated from Cleveland Medical College, Homeopathic in 1992.

Dr. Mastroianni is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.